Why is GSK plc (GSK) One of the Best Affordable Healthcare Stocks to Buy Now? [Yahoo! Finance]
GlaxoSmithKline PLC (GSK)
US:NYSE Investor Relations:
gsk.com/en-gb/investors
Company Research
Source: Yahoo! Finance
United States administration to lower the cost of prescription medications for patients in the US, which includes the company's broad respiratory portfolio targeting the treatment of over 40 million Americans suffering from respiratory conditions such as COPD and asthma. The agreement entails GSK plc (NYSE:GSK) lowering the price of certain medicines in Medicaid, along with launching new products with a higher balance pricing approach that recognises the value of innovation across developed nations. Management reported that the agreement satisfies all four actions requested by President Trump in his July 31st letter. GSK plc (NYSE:GSK) added that it would also “make most” of its inhaled respiratory portfolio, along with other products available to patients, on a direct purchasing platform offering up to 66% of savings. In addition, management reported that as part of the President's Strategic Active Pharmaceutical Ingredients Reserve (SAPIR), the company would support the resilien
Show less
Read more
Impact Snapshot
Event Time:
GSK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GSK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GSK alerts
High impacting GlaxoSmithKline PLC news events
Weekly update
A roundup of the hottest topics
GSK
News
- GSK (NYSE:GSK) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.MarketBeat
- Jefferies Reaffirms a Buy Rating on GSK plc (GSK) – Here's Why [Yahoo! Finance]Yahoo! Finance
- GSK (NYSE:GSK) was downgraded by analysts at Barclays PLC from an "equal weight" rating to an "underweight" rating.MarketBeat
- HSBC Sees Pharma Poised to Outperform in 2026, Lifts GSK Target [Yahoo! Finance]Yahoo! Finance
- Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSKPR Newswire
GSK
Sec Filings
- 1/16/26 - Form 6-K
- 1/15/26 - Form 6-K
- 1/13/26 - Form 6-K
- GSK's page on the SEC website